Back to search
FDAFDA · Food and drugs·Recall number D-802-2013

QUETIAPINE Fumarate Tablets 25mg 100 Tablets (10x10) Blister card, Rx, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC 68084-530-01

Published July 24, 2013 · Recall initiated: October 10, 2012

Summary

FDA records drug Class II recall D-802-2013, published July 24, 2013 and initiated October 10, 2012. Recalling firm: American Health Packaging; Status: Terminated; Reported quantity: 19060 blister cards; Lot: Lot 122600 Exp. 03/14. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Test Requirements: During analysis of long term stability studies at 3 months time point, an OOS was reported for Quetiapine Fumarate Tablets, 25 mg.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
American Health Packaging
Distributor
Nationwide
Lot
Lot 122600 Exp. 03/14
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was QUETIAPINE Fumarate Tablets 25mg 100 Tablets (10x10) Blister card, Rx, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC 68084-530-01 recalled?

Yes. FDA published recall D-802-2013 on July 24, 2013. Reported hazard: Failed Dissolution Test Requirements: During analysis of long term stability studies at 3 months time point, an OOS was reported for Quetiapine Fumarate Tablets, 25 mg.

What should I do if I have this product?

Voluntary: Firm initiated · Letter